Apalutamide
Janssen
['docetaxel']
docetaxel plus potent ar inhibition improves long term remission rates with salvage rt in high risk men. see our startar trial #asco23 abstract 5016 
Professor of Medicine, Surgery, Pharmacology and Cancer Biology, Duke Cancer Institute, Durham NC